Investors
Investors
April 27, 2018

Sanofi will present its First Quarter 2018 Results

At a glance

General Meeting 2018
May 2, 2018

General Meeting 2018

The Sanofi General Meeting will be held on May 2, 2018 at the Palais des Congrès in Paris.
IR call on the acquisition of Bioverativ
ACQUISITION

Tender offers by Sanofi to acquire Ablynx

Bill Sibold
BROKER CONFERENCES

Cowen Healthcare Conference - Bill Sibold

March 12, 2018
IR call on the acquisition of Bioverativ
INVESTOR PRESENTATIONS

IR call on the acquisition of Bioverativ

January 22, 2018

Contact the Investor Relations team

54 rue La Boétie
75008 Paris FRANCE

France +33 (0)1 53 77 45 45 • ir@sanofi.com

United States +1 908 981 5560

Press releases

Press releases

In-depth reading

Investor Relations conference call on the results of Odyssey Outcomes
March 10, 2018

Investor Relations conference call on the results of Odyssey Outcomes

Sanofi and Regeneron hosted a conference call for the financial community on the results of the ODYSSEY OUTCOMES study.
Olivier Brandicourt
Broker conferences

JP Morgan Healthcare Conference - Olivier Brandicourt

January 9, 2018
Sustaining Innovation Day
Investor presentations

Sustaining Innovation Day

December 13, 2017
2017 Dividend

2017 Dividend

Board proposes dividend of €3.03, an increase of 2.4%
Annual Report on Form 20-F 2017

Annual Report on Form 20-F 2017

Individual shareholders

Direct access to Individual shareholders - Welcome to Sanofi

Access your dedicated section

Shareholder Handbook 2017

Shareholder Handbook 2017

Integrated Report 2016

Letter to shareholders March 2018

Sanofi IR app on different devices

SANOFI IR
The Investor Relations app

SANOFI IR provides financial information with direct access to key news, events, publications and a dedicated section for individual shareholders
Download the IR app on the App Store Get the IR app on Google Play